BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22083578)

  • 1. Acid suppressive therapy in noncritically ill patients.
    Barletta JF; El-Ibiary SY
    Arch Intern Med; 2011 Nov; 171(20):1861; author reply 1861-2. PubMed ID: 22083578
    [No Abstract]   [Full Text] [Related]  

  • 2. Acid-suppressive medication use and the risk for nosocomial gastrointestinal tract bleeding.
    Herzig SJ; Vaughn BP; Howell MD; Ngo LH; Marcantonio ER
    Arch Intern Med; 2011 Jun; 171(11):991-7. PubMed ID: 21321285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically Significant Gastrointestinal Bleeding Using Proton Pump Inhibitors or Histamine Type-2 Receptor Antagonists in Patients Intubated for over 48 Hours: A Systematic Review and Meta-Analysis.
    Khokher W; Kesireddy N; Iftikhar S; Beran A; Abuhelwa Z; Malhas SE; Saif T; Rashid R; Ali H; Malik A; Assaly R
    Am J Ther; 2024 Jan-Feb 01; 31(1):e62-e66. PubMed ID: 35703440
    [No Abstract]   [Full Text] [Related]  

  • 4. Common drugs can harm elderly patients.
    Voelker R
    JAMA; 2009 Aug; 302(6):614-5. PubMed ID: 19671895
    [No Abstract]   [Full Text] [Related]  

  • 5. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
    MacLaren R; Reynolds PM; Allen RR
    JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.
    Abraham NS; Hlatky MA; Antman EM; Bhatt DL; Bjorkman DJ; Clark CB; Furberg CD; Johnson DA; Kahi CJ; Laine L; Mahaffey KW; Quigley EM; Scheiman J; Sperling LS; Tomaselli GF;
    Am J Gastroenterol; 2010 Dec; 105(12):2533-49. PubMed ID: 21131924
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk of Clostridium difficile infection with acid-suppressive therapy; pitfalls in accurate estimation.
    Chandra S; Agarwal D; Surana A
    Am J Gastroenterol; 2013 Feb; 108(2):277-8. PubMed ID: 23381074
    [No Abstract]   [Full Text] [Related]  

  • 8. Prophylaxis against Upper Gastrointestinal Bleeding in Hospitalized Patients.
    Cook D; Guyatt G
    N Engl J Med; 2018 Jun; 378(26):2506-2516. PubMed ID: 29949497
    [No Abstract]   [Full Text] [Related]  

  • 9. Gastric Acid Suppressant Prophylaxis in Pediatric Intensive Care: Current Practice as Reflected in a Large Administrative Database.
    Costarino AT; Dai D; Feng R; Feudtner C; Guevara JP
    Pediatr Crit Care Med; 2015 Sep; 16(7):605-12. PubMed ID: 25901549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors therapy vs H2 receptor antagonists therapy for upper gastrointestinal bleeding after endoscopy: A meta-analysis.
    Zhang YS; Li Q; He BS; Liu R; Li ZJ
    World J Gastroenterol; 2015 May; 21(20):6341-51. PubMed ID: 26034370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histamine 2 Receptor Antagonists and Proton Pump Inhibitors.
    Brinkworth MD; Aouthmany M; Sheehan M
    Dermatitis; 2016; 27(3):100-9. PubMed ID: 27172303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adverse effects of gastric acid suppressive drugs].
    Haruma K; Kamada T; Shiotani A
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():198-201. PubMed ID: 18074539
    [No Abstract]   [Full Text] [Related]  

  • 13. ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
    Abraham NS; Hlatky MA; Antman EM; Bhatt DL; Bjorkman DJ; Clark CB; Furberg CD; Johnson DA; Kahi CJ; Laine L; Mahaffey KW; Quigley EM; Scheiman J; Sperling LS; Tomaselli GF;
    Circulation; 2010 Dec; 122(24):2619-33. PubMed ID: 21060077
    [No Abstract]   [Full Text] [Related]  

  • 14. Association Between Preadmission Acid Suppressive Medication Exposure and Severity of Illness in Patients Hospitalized With COVID-19.
    Elmunzer BJ; Wolf BJ; Scheiman JM; Tierney WM; Taylor JR;
    Gastroenterology; 2021 Mar; 160(4):1417-1422.e14. PubMed ID: 33189702
    [No Abstract]   [Full Text] [Related]  

  • 15. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
    Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
    Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid suppressants and hip fracture: duplicate publication bias?
    Bazelier M; de Boer A; de Vries F
    Bone; 2011 Oct; 49(4):920; author reply 921. PubMed ID: 21820528
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acid inhibition leads to vitamin b12 deficiency].
    Zwicker J
    Med Monatsschr Pharm; 2014 May; 37(5):190-1. PubMed ID: 24908938
    [No Abstract]   [Full Text] [Related]  

  • 18. Histamine H2-Blocker and Proton Pump Inhibitor Use and the Risk of Pneumonia in Acute Stroke: A Retrospective Analysis on Susceptible Patients.
    Arai N; Nakamizo T; Ihara H; Koide T; Nakamura A; Tabuse M; Miyazaki H
    PLoS One; 2017; 12(1):e0169300. PubMed ID: 28085910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitors and Raynaud's phenomenon: is there a link?
    Khouri C; Revol B; Cracowski JL; Roustit M
    Br J Clin Pharmacol; 2018 Oct; 84(10):2443-2444. PubMed ID: 30003585
    [No Abstract]   [Full Text] [Related]  

  • 20. Pregnancy and drugs used in gastro-oesophageal reflux.
    Prescrire Int; 2015 Dec; 24(166):297-9. PubMed ID: 26788579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.